
Please try another search
Evercore ISI initiated coverage on GE HealthCare (GEHC) with an Outperform rating and a price target of $90.00.
The company, which was previously part of General Electric Company (GE) until the spin-off of GE Healthcare in January 2023, is a leading medical technology company focused on Medical Imaging (Imaging & Ultrasound account for approximately 75% of revenues).
“Rev acceleration thesis rests on pricing & innovation. FY23 contemplates 2-3% of pricing, & going fwd GEHC expects 1-2% of net pricing…with historical volume growth of ~4%, a positive price by itself could push revs to MSD,” said the firm.
R&D investment has increased by approximately 100 basis points and is projected to outpace revenue growth. Management is prioritizing NPI metrics to maintain revenue growth, and there is potential for significant upside with breakthrough technologies such as photon counting CT. In terms of margins, positive pricing and platforming initiatives (such as pooling purchasing and minimizing SKUs) could boost margins by 50-100 basis points on an annual basis, said the firm.
Currently, shares are trading nearly 2% higher.
By Davit Kirakosyan
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.